ProMED
ProMED (ProMed, LLC) is a privately held Addison, TX medical device company that sells FDA 510(k)-cleared autonomic nervous system diagnostic equipment — including the BioScan, SudoCheck, and VitalScan ANS PWV Pro systems — to U.S. physician practices, and provides wound care and allergy testing services in the Dallas metro area.
- Company typePrivate
- Founded-
- HeadquartersDallas, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What ProMED does
ProMED (legal entity ProMed, LLC) is a privately held medical device and diagnostic services company headquartered in Addison, Texas (Dallas metro area). The company's core business is the development, sale, and support of autonomic nervous system (ANS) diagnostic equipment sold to physician practices and medical clinics across the United States. Its product portfolio centers on three proprietary systems: the ProMed ANS BioScan System, which performs non-invasive Heart Rate Variability (HRV), blood pressure, and Pulse Wave Velocity analysis; the SudoCheck System, a sudomotor test for early detection of diabetic neuropathy and cardiometabolic risk; and the VitalScan ANS PWV Pro, an FDA 510(k) cleared and CE Marked comprehensive ANS testing platform backed by 30+ years of clinical research and a normative database of more than 50,000 assessments. All three products are positioned for early detection of autonomic dysfunction, cardiovascular autonomic neuropathy, and peripheral neuropathies, particularly in diabetic populations.
ProMED generates revenue through a mix of one-time hardware sales of diagnostic equipment, associated consumables, and recurring professional services. The company has expanded into adjacent service lines, including chronic wound care using amniotic membrane allografts (processed by Celularity under an FDA-regulated HCTP framework) delivered across clinic, assisted living, and home settings, as well as physician office-based allergy testing in the Dallas area. The go-to-market is sales-led, with direct outreach to physician practices supplemented by Medicare-compatible insurance billing support and revenue cycle management services that help practices integrate and monetize the diagnostic offerings. The company emphasizes practice revenue enhancement alongside clinical utility as a key value proposition.
ProMED firmographics
Firmographics- Name
- ProMED
- Legal name
- ProMed, LLC
- Website
- https://gopromed.net
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ProMED (ProMed, LLC) is a privately held Addison, TX medical device company that sells FDA 510(k)-cleared autonomic nervous system diagnostic equipment — including the BioScan, SudoCheck, and VitalScan ANS PWV Pro systems — to U.S. physician practices, and provides wound care and allergy testing services in the Dallas metro area.
- Ownership category
- akta.pro rank
ProMED industry classification
Industry- Product category
- Medical Diagnostic Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where ProMED is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ProMED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Medical Equipment Sales: Sale of ANS diagnostic equipment including BioScan System and VitalScan ANS PWV Pro to physician practices and healthcare facilities.
- Diagnostic Testing Solutions: Provide customized testing platforms that enable physicians to diagnose autonomic nervous system disorders and peripheral neuropathies. Revenue generated through equipment sales and associated consumables.
- Wound Care Treatments: Chronic wound care treatment services using amniotic membrane allografts. Services provided in clinic, assisted living facilities, and at home settings.
- Revenue Cycle Management Services: Billing best practices and insurance claim support including Medicare billing codes, helping physician practices optimize reimbursement for diagnostic services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
ProMED product offering
Product offeringCore offering
ProMED sells proprietary medical diagnostic equipment — including the ProMed ANS BioScan System, SudoCheck System, and VitalScan ANS PWV Pro — that enable physicians to perform non-invasive autonomic nervous system testing, diabetic neuropathy detection, and cardiovascular assessment. The company also provides wound care treatments using amniotic membrane allografts and supports practices with technical training, operational support, and Medicare-compliant billing guidance.
Product overview
ProMED provides a portfolio of medical diagnostic solutions centered on autonomic nervous system testing and peripheral neuropathy detection. The core platform is the VitalScan ANS PWV Pro system, which serves as the primary testing platform, complemented by the ProMed ANS BioScan System for HRV and cardiovascular assessment, and the SudoCheck System for sudomotor function and diabetic neuropathy testing. The company also offers wound care services using amniotic membrane allografts and allergy testing services. All ANS testing devices are designed to enable early detection of autonomic dysfunction before symptoms appear.
Differentiator
Problem solved
Functional benefit
Products and services
- ProMed ANS BioScan System®
Quantifiable outcome
- Early detection of diabetic neuropathy before symptoms appear, when 5-year survival rates are significantly higher
- +1 more outcomes
Companies that use ProMED
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
ProMED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
ProMED partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CelularitycoreCelularity processes the amniotic membrane allografts used in ProMED's wound care treatments. Placenta tissue is collected from approved donors and sent to Celularity labs for purification and processing. The allograft is regulated as a human cellular tissue product (HCTP) by FDA, and the facility is accredited by the American Association of Blood Banks (AABB).
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
ProMED competitors and assessment
Company assessmentDirect peers
- Organogenesis: Organogenesis markets Apligraf and other advanced wound care biologics, competing directly with ProMED's amniotic membrane allograft wound care service in physician clinics and wound-care centers.
- Itamar Medical: Itamar Medical (now part of ZOLL/ResMed) developed the EndoPAT system for endothelial function and autonomic assessment, directly competing with ProMED's BioScan/VitalScan HRV-based ANS diagnostics in physician-office cardiovascular autonomic testing.
- MiMedx: MiMedx is a leading amniotic membrane allograft supplier for wound care, comparable to ProMED's Celularity-sourced wound-care allograft offering and a direct competitor for advanced chronic-wound treatment revenue.
- Finapres Medical Systems: Finapres produces non-invasive continuous blood pressure and cardiovascular monitoring equipment (Finapres NOVA), directly comparable to ProMED's blood pressure analysis and pulse wave velocity modules in ANS and cardiovascular diagnostics.
- CNSystems: CNSystems manufactures the Task Force Monitor for continuous non-invasive hemodynamic and autonomic nervous system assessment, making it a direct peer to ProMED's BioScan/VitalScan ANS testing platform in physician and cardiology practices.
Broad incumbents
- Philips: Philips provides cardiovascular and patient monitoring systems that can substitute for ProMED's HRV/PWV diagnostics as part of a broader diagnostic portfolio sold into hospitals and integrated delivery networks.
- Smith+Nephew (Advanced Wound Management): Smith+Nephew's Advanced Wound Management portfolio overlaps with ProMED's wound-care service line as a broad incumbent offering dressings, NPWT, and biologics across hospital, clinic, and home-care settings.
- GE Healthcare: GE Healthcare's patient monitoring and cardiology diagnostic suites (e.g., MAC ECG, CARESCAPE) compete with ProMED's electrophysiology-based ANS diagnostics at the integrated health-system buyer level.
- Welch Allyn (Baxter): Welch Allyn (now part of Baxter) supplies physician-office diagnostic devices including vital signs monitors and ECG, representing the kind of broad incumbent ProMED competes against for the same primary-care budget.
- Hologic: Hologic operates in women's health and office-based diagnostics, an adjacent clinical footprint to ProMED's primary-care physician channels where ANS testing and specialty diagnostics share purchasing committees.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
ProMED social profiles
Digital presenceProMED compliance and trust
Trust signalCompliance4 records
ProMED financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProMED leadership team
Management profileNumber of profiles
ProMED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProMED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProMED
What does ProMED do?
ProMED sells proprietary medical diagnostic equipment — including the ProMed ANS BioScan System, SudoCheck System, and VitalScan ANS PWV Pro — that enable physicians to perform non-invasive autonomic nervous system testing, diabetic neuropathy detection, and cardiovascular assessment. The company also provides wound care treatments using amniotic membrane allografts and supports practices with technical training, operational support, and Medicare-compliant billing guidance.
Is ProMED a public or private company?
ProMED is a private company. It is classified as unknown and is currently operating.
When was ProMED founded?
ProMED was founded in -1. It employs 1 to 10 people.
Where is ProMED based?
ProMED is headquartered in Dallas, United States, in the North America region.
How does ProMED make money?
Four revenue lines are on record. Medical Equipment Sales are the primary driver. The others are diagnostic Testing Solutions, wound Care Treatments and revenue Cycle Management Services.
Who are ProMED's main competitors?
Direct peers on record are Organogenesis, Itamar Medical, MiMedx, Finapres Medical Systems and CNSystems. Broad incumbents are Philips, Smith+Nephew (Advanced Wound Management), GE Healthcare, Welch Allyn (Baxter) and Hologic.
Does ProMED have an API?
No public API is recorded for ProMED.
What industry is ProMED in?
ProMED's product category is Medical Diagnostic Equipment. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3845.